Skip to content

Cancers & treatments

News & evidence

Living with cancer

Learn & contribute

Loading

A public, cited, editable map of oncology: technologies, targets, products, companies, institutions, pathways, trials, pairings, roadmaps, and ideas. One page per object, with a plain-language TL;DR on every page.

Work in progress. Every fact on this site is being built and checked in the open and may be incomplete, out of date, or wrong. You must do your own research and verify anything here at its primary source before relying on it. Nothing on this site is medical advice; decisions belong with you and your clinicians.

OnCo is an information resource, not medical advice. Nothing here replaces a conversation with a qualified clinician. Never delay care because of something you read here; in an emergency, call your local emergency services. Terms of use

Browse by cancer
Tags
Search
Connections
For me
Navigator
Biomarker matrix
Calculators
Interactions
Decision aids
Checkpoint side effects
Tumour board
Compare
Counts by category
Rankings
Timeline
Year by year
Query builder
Graph explorer
Saved
Body map

Cancers & treatments

News & evidence

Institutions & people

Living with cancer

For me
The first 60 days
Appointment prep pack
Side effects
Symptom to test
Report reader
Survivorship planner
Second opinion
Financial help
Free in oncology
Paying for care in the US
NHS coverage
Paying for care in India
Coverage rankings
Cutting cancer care costs
Diet, exercise and lifestyle
Supportive care
Recovery and rejuvenation
Complementary and supportive approaches
Hair loss and regrowth
What comes back after treatment
How precise cancer care is
Heroes and heroines

Learn & contribute

Reading paths
About & methodology
Roadmap
Gaps to fill
Coverage of the field
Review queue
Reviewer roster
Contributors
Idea votes
Teaching packs
Weekly issue
Suggest an edit
Answer quality
Data dictionary
Build on OnCo
Open API
Open data
Open tools
Open source in oncology
The software of oncology
GitHub

© 2026 OnCo. Code MIT. The data are free for individual and educational use with the attribution “Data from OnCo (onco.cc)”, under CC BY-NC 4.0. Commercial use must contact us to pay for the data. Commercial licences. Made with heart and soul by Jude Gomila .

About and methodology Corrections Open API Tags Terms of use Privacy policy GitHub

Loading

Home
Cancers
Lung neuroendocrine tumours (typical and atypical carcinoid)
Data

Cancers·Lung neuroendocrine tumours (typical and atypical carcinoid)

DataLung neuroendocrine tumours (typical and atypical carcinoid)

Back to the Lung neuroendocrine tumours hub →49 connected records · 1 note

Every connected record, the notes, the JSON, Markdown and RDF twins, and where the record came from and when it was checked.

Overview Types and stages Symptoms and diagnosis Treatment Trials and papers Biology and targets Countries and centres Decisions and support Pipeline and open problems Data

Data

Related pages

49

Direct links plus the targets, companies, and technologies of this cancer's products.

Similar pages

Cancer
Hereditary pheochromocytoma and paraganglioma (SDHx, VHL, RET, NF1, MAX and TMEM127)
Shares Somatostatin receptor PET (68Ga/64Cu-DOTATATE), Peptide receptor radionuclide therapy (PRRT), Lutetium-177 dotatate, Somatostatin receptor 2 and the tags subtype-page, endocrine.
Cancer
Metastatic pheochromocytoma and paraganglioma
Shares Somatostatin receptor PET (68Ga/64Cu-DOTATATE), Peptide receptor radionuclide therapy (PRRT), Lutetium-177 dotatate, Small intestinal neuroendocrine tumours and the tags subtype-page, endocrine.
Cancer
Localised adrenocortical carcinoma (ENSAT stage I to III, resectable)
Shares CT (computed tomography), Robotic & minimally invasive surgery and the tags subtype-page, endocrine.
Cancer
Limited-stage small-cell lung cancer
Shares Lobectomy, Small-cell lung cancer and the tags subtype-page, lung.
Cancer
Resectable stage I to III non-small-cell lung cancer
Shares Bronchoscopy (EBUS, robotic navigation), Lobectomy, CT (computed tomography), Robotic & minimally invasive surgery and the tags subtype-page, lung.
Cancer
Advanced and metastatic adrenocortical carcinoma (ENSAT stage IV or unresectable)
Shares Cabozantinib and the tags subtype-page, endocrine.
Cancer
EGFR-mutated non-small-cell lung cancer
Shares Lobectomy and the tags subtype-page, lung.
Cancer
Extensive-stage small-cell lung cancer
Shares Small-cell lung cancer and the tags subtype-page, lung.

technologies

Anti-angiogenic therapy CT (computed tomography)Cytotoxic chemotherapy Peptide receptor radionuclide therapy (PRRT)PET/CT PI3K, AKT and mTOR inhibitors Radioligand therapy (beta emitters)Robotic & minimally invasive surgery Small-molecule kinase inhibitors Somatostatin receptor PET (68Ga/64Cu-DOTATATE)

targets

AKT MET mTOR RET Somatostatin receptor 2 VEGF / VEGFR

drugs

ApprovedSmall-molecule multi-kinase inhibitor (MET, VEGFR2, AXL, RET)

Cabozantinib · Cabometyx

EstablishedOral cytotoxic regimen

Capecitabine + temozolomide (CAPTEM)

ApprovedSmall-molecule mTOR inhibitor

Everolimus · Afinitor

ApprovedRadioligand therapy (beta)

Lutetium-177 dotatate · Lutathera

ApprovedMultireceptor somatostatin analogue (subcutaneous or monthly depot)

Pasireotide · Signifor / Signifor LAR

ApprovedPeptide hormone analogue (SSTR2 agonist)

Somatostatin analogues (octreotide, lanreotide) · Sandostatin LAR, Somatuline Depot

Imaging agents

ApprovedPET radiotracer (somatostatin receptor ligand)

Gallium-68 DOTATATE (and Cu-64 DOTATATE) · Netspot / Detectnet

companies

Curium Exelixis Ipsen Novartis Recordati

institutions

Neuroendocrine Cancer Foundation

terms

Bronchoscopy (EBUS, robotic navigation)Carcinoid syndrome and carcinoid heart disease Chromogranin A Lobectomy Neuroendocrine tumour grade (Ki-67) and WHO classification TNM 9: what changed in lung cancer staging TTF-1 and p40 (how lung histology is decided)

trials

CABINET (Alliance A021602)CLARINET RADIANT-3 and RADIANT-4 SPINET Study to Evaluate the Efficacy and Safety of Lutathera in Patients With Grade 2 and Grade 3 Advanced GEP-NET Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors

collections

Pattern.org and the Pattern Biobank

people

Jennifer A. Chan

key papers

CABINET (Alliance A021602): cabozantinib for advanced neuroendocrine tumours ENETS expert consensus on pulmonary neuroendocrine (carcinoid) tumours RADIANT-4: everolimus for advanced non-functional neuroendocrine tumours of the lung or gastrointestinal tract

biomarkers

Ki-67 index (proliferation by IHC)Somatostatin receptor expression by PET (SSTR-positive)

Notes

Where carcinoid sits in the lung family. The 2021 WHO classification of thoracic tumours puts typical carcinoid, atypical carcinoid, large cell neuroendocrine carcinoma and small cell carcinoma in one neuroendocrine chapter, so the neuroendocrine spectrum crosses the clinical small-cell and non-small-cell split that organises the rest of the lung family. This corpus keeps the carcinoids under the neuroendocrine family page, where the somatostatin-analogue and peptide receptor radionuclide pages sit beside them, and keeps small cell carcinoma and large cell neuroendocrine carcinoma under lung cancer; all three are cross-linked. The reasoning is set out in the taxonomy section of docs/CANCER-PAGES.md.

Machine-readable versions

The same record for scripts and assistants; checked 2026-09-17. Data CC BY-NC 4.0, attribute “Data from OnCo (onco.cc)”.

JSON with neighbours Markdown context RDF Turtle Sections with routes and counts API root

Wikipedia

Neuroendocrine tumor

subtype-page endocrine lung

Make correction

Machine-readable versions of Lung neuroendocrine tumours (typical and atypical carcinoid)

JSON record with neighbours
Markdown context for language models
RDF Turtle for this record (its triples, relations and owl:sameAs; the IRI of this record is https://onco.cc/cancers/lung-net/)
Section plan: the ten sections of this record with routes, anchors and counts
All cancers as JSON
RDF N-Triples for the whole corpus
Search index: id, kind, name, TL;DR and route for every record
OpenAPI 3.1 description
API root and meta.json
llms.txt

MCP server: npx -y onco-mcp, tools search, get_entity, list_kind, ask, context, compare. This record is get_entity or context with id lung-net.

WebMCP tools registered on this page: onco_search, onco_get_entity.